Investigation of the 188Re Eluate Suitability for Medical Purposes by Labeling a Bombesin Analog (BN1.1)

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|2|4|295-303

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.2, Iss.4, 2009-10, pp. : 295-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rhenium-188: Availability from the 188W/188Re Generator and Status of Current Applications

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 3, 2012-07 ,pp. : 228-243

Bentham Science Publishers

Access to resources Recommend Favorite

Sex selection for non-medical purposes

By Milliez JM  

Reproductive BioMedicine Online, Vol. 14, Iss. 1, 2007-02 ,pp. : 114-117

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies

By Schwartsmann G.   DiLeone L.   Horowitz M.   Schunemann D.   Cancella A.   Pereira A.   Richter M.   Souza F.   Rocha A.   Souza F.   Pohlmann P.   Nucci G.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 403-412

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of 188Re-labeled pentaphosphonic acid in rats with experimental bone callosity

By Shiryaeva V.   Petriev V.   Smoryzanova O.   Skvortsov V.  

Pharmaceutical Chemistry Journal, Vol. 47, Iss. 5, 2013-08 ,pp. : 251-256

Springer Publishing Company

Access to resources Recommend Favorite

Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188

By Karekar Poonam   Vyas Vikrant   Shah Manali   Sancheti Pankajkumar   Pore Yogesh  

Pharmaceutical Development and Technology, Vol. 14, Iss. 4, 2009-08 ,pp. : 373-379

Informa Healthcare

Access to resources Recommend Favorite